New drug approach offers hope for patients with recurrent aggressive cancers Merck announces that sac-TMT, a new cancer drug, demonstrated strong results in phase 3 trials for advanced or recurrent endometrial cancer patients. Original Source: https://www.foxnews.com/health/new-drug-approach-offers-hope-patients-recurrent-aggressive-cancers
